Respiratory Distress Syndrome
📧 Sign up to get email alerts when something new happens for Respiratory Distress Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS) [Phase 1]
Phase 1 clinical trial evaluating defibrotide therapy for COVID-19–related acute respiratory distress syndrome is completed; results posted …
-
CLINICAL_TRIALS trial_result · 2023-04-11Clinical Trial Update: Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS [Phase 2]
Phase 2 trial update on extracellular vesicle infusion for COVID-19-associated ARDS, completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-06Clinical Trial Update: Tenecteplase in Patients With COVID-19 [Phase 2]
Phase 2 trial update for tenecteplase in COVID-19 patients with respiratory failure completed, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-04-05Clinical Trial Update: Protective Effect of Sivelestat Sodium on ARDS in Patients With Sepsis [Phase 3]
Phase 3 clinical trial evaluating whether sivelestat sodium provides a protective effect in acute respiratory distress syndrome (ARDS) patie…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Effect of Desflurane on Pediatric Acute Respiratory Distress Syndrome After Living Donor Liver Transplant Recipients [Phase 4]
Phase 4 clinical trial evaluating the effect of desflurane on pediatric acute respiratory distress syndrome in living donor liver transplant…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2023-03-22Clinical Trial Update: Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19 [Phase 4]
A Phase 4 trial comparing two dexamethasone doses in patients with ARDS and COVID-19 has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Using TEE to Evaluate the Effect of Levosimendan on Patients With ARDS Associated With RVD During MV [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating levosimendan effects on ARDS with right ventricular dysfunction in mechanically ventilated patients, usi…
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome [Phase 2]
Phase 2 clinical trial update on using calcifediol for prevention and treatment of COVID-19 induced acute respiratory syndrome; trial comple…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia [Phase 3]
Phase 3 clinical trial update evaluating early dexamethasone administration in hospitalized COVID-19 pneumonia patients. Current status is u…
-
CLINICAL_TRIALS withdrawal · 2023-02-03Clinical Trial Update: Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19 [Phase 3]
Phase 3 clinical trial of inhaled aviptadil acetate (ZYESAMI) for severe COVID-19 has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-02-03Clinical Trial Update: Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19 [Phase 2, Phase 3]
Phase 2/3 trial of inhaled aviptadil acetate (ZYESAMI) for severe COVID-19 was terminated.
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Inhalational (Sevoflurane) Versus Intravenous (Propofol) Sedation in Adults With a Moderate Form of ARDS [Phase 3]
Phase 3 trial comparing inhalational sevoflurane versus intravenous propofol for sedation in adults with moderate acute respiratory distress…
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19 [Phase 1, Phase 2]
Phase 1/2 trial evaluating mesenchymal stem cells for efficacy and safety in patients with respiratory distress from COVID-19 has completed.
-
CLINICAL_TRIALS trial_result · 2023-01-09Clinical Trial Update: Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 [Phase 2, Phase 3]
Phase 2/3 trial on safety and efficacy of hyperbaric oxygen for ARDS in COVID-19 patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome [Phase 4]
Phase 4 clinical trial update for an adaptive embedded platform study in acute respiratory distress syndrome.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: hCT-MSCs for COVID19 ARDS [Phase 1, Phase 2]
Phase 1/2 trial of human umbilical cord tissue-derived mesenchymal stem cells (hCT-MSCs) for COVID-19–related ARDS was terminated; results p…
-
CLINICAL_TRIALS trial_result · 2022-11-17Clinical Trial Update: Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19 [Phase 2]
Phase 2 trial evaluating PLN-74809 in acute respiratory distress syndrome (ARDS) associated with severe COVID-19; study terminated with resu…
-
CLINICAL_TRIALS trial_result · 2022-07-27Clinical Trial Update: A Study of Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19) [Phase 3]
Phase 3 trial of brexanolone for ARDS due to COVID-19 was terminated with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-07-22Clinical Trial Update: A Phase 2 Study to Evaluate Axatilimab for Hospitalized Participants With Respiratory Involvement Secondary to COVID-19 [Phase 2]
Phase 2 study evaluating axatilimab for hospitalized COVID-19 patients with respiratory involvement was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-07-12Clinical Trial Update: Mineralocorticoid Use in COVID-19 Patients [Phase 3]
Phase 3 clinical trial update on mineralocorticoid use in COVID-19 patients, completed.
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19 [Phase 2]
A Phase II clinical trial update for a treatment in patients with moderate to severe ARDS due to COVID-19.
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: Effect of Bronchoscopy on the Outcome of Patients With Severe Sepsis With ARDS and Complicated by VAP From Prolonged Ventilation [Phase 1, Phase 2]
Clinical trial update reporting completed Phase 1/2 study on bronchoscopy impact in patients with severe sepsis and ARDS complicated by VAP …
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: Losartan for Patients With COVID-19 Requiring Hospitalization [Phase 2]
A Phase 2 clinical trial evaluating losartan for hospitalized COVID-19 patients has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: Inhaled Steroids for the Treatment of Early Pediatric Acute Respiratory Distress Syndrome [Phase 2]
Phase 2 trial evaluating inhaled steroids for early pediatric acute respiratory distress syndrome was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia [Phase 3]
Phase 3 trial of IV ravulizumab in COVID-19 severe pneumonia was terminated; results posted but no ongoing study.